NEW YORK (GenomeWeb) – Finnish molecular diagnostics firm Mobidiag announced today that it has signed on Bioportugal Quimica Farmaceutica as the exclusive distributor of its Amplidiag in vitro diagnostic products in Portugal.
The Amplidiag line includes PCR-based tests for various gastrointestinal infections including two CE-IVD marked assays — Bacterial GE, which detects Campylobacter, Salmonella, Shigella, Yersinia, and five different Escherichia coli pathotypes; and Amplidiag C. difficile+27 for identifying toxin-producing Clostridium difficile — as well as the Amplidiag Easy automated platform that runs the tests. The firm also sells Amplidiag tests for H. pylori and stool parasites, and CarbaR+VRE, which identifies five major carbapenemase groups and two vancomycin resistance markers.
Specific terms of the distribution agreement were not disclosed.
"For the past months, we have been extending significantly our European distribution network," Mobidiag CEO Tuomas Tenkanen said in a statement. "With a strong background in diagnostics, Bioportugal seemed to be the clear choice to distribute our IVD tests in Portugal."
Earlier this month, Mobidiag named Biomedica Medizinprodukte as the exclusive distributor of the Amplidiag line in Central and Eastern Europe. In June, it signed a distribution deal with Isogen Life Sciences covering Belgium, the Netherlands, Luxembourg, and Spain. And last year, it made Unilabs its Amplidiag distributor in Norway.